Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. more
Time Frame | VTRS | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.87% | -2.12% | -2.22% |
1-Month Return | -4.65% | -3.42% | 0.07% |
3-Month Return | 9.92% | -11.13% | 3.71% |
6-Month Return | 22.03% | -5.74% | 8.04% |
1-Year Return | 19.81% | 3.97% | 26.32% |
3-Year Return | -1.88% | 1.05% | 29.42% |
5-Year Return | -36.74% | 34.37% | 83.36% |
10-Year Return | -78.04% | 97.88% | 185.56% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 11.50B | 11.95B | 17.89B | 16.26B | 15.43B | [{"date":"2019-12-31","value":64.3,"profit":true},{"date":"2020-12-31","value":66.79,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.92,"profit":true},{"date":"2023-12-31","value":86.25,"profit":true}] |
Cost of Revenue | 7.60B | 8.15B | 12.31B | 9.77B | 8.99B | [{"date":"2019-12-31","value":61.76,"profit":true},{"date":"2020-12-31","value":66.2,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":79.33,"profit":true},{"date":"2023-12-31","value":73.01,"profit":true}] |
Gross Profit | 3.90B | 3.80B | 5.58B | 6.50B | 6.44B | [{"date":"2019-12-31","value":59.99,"profit":true},{"date":"2020-12-31","value":58.44,"profit":true},{"date":"2021-12-31","value":85.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.1,"profit":true}] |
Gross Margin | 33.89% | 31.78% | 31.17% | 39.95% | 41.74% | [{"date":"2019-12-31","value":81.2,"profit":true},{"date":"2020-12-31","value":76.15,"profit":true},{"date":"2021-12-31","value":74.69,"profit":true},{"date":"2022-12-31","value":95.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 3.20B | 3.86B | 5.21B | 4.84B | 5.67B | [{"date":"2019-12-31","value":56.48,"profit":true},{"date":"2020-12-31","value":68,"profit":true},{"date":"2021-12-31","value":91.85,"profit":true},{"date":"2022-12-31","value":85.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (1.37B) | (210.80M) | (34.00M) | 1.61B | 766.20M | [{"date":"2019-12-31","value":-84.77,"profit":false},{"date":"2020-12-31","value":-13.05,"profit":false},{"date":"2021-12-31","value":-2.11,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":47.45,"profit":true}] |
Total Non-Operating Income/Expense | 1.01B | (1.01B) | (1.27B) | 605.90M | (1.14B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-100.21,"profit":false},{"date":"2021-12-31","value":-125.89,"profit":false},{"date":"2022-12-31","value":60.22,"profit":true},{"date":"2023-12-31","value":-113.57,"profit":false}] |
Pre-Tax Income | 154.40M | (721.20M) | (664.40M) | 2.81B | 202.90M | [{"date":"2019-12-31","value":5.49,"profit":true},{"date":"2020-12-31","value":-25.64,"profit":false},{"date":"2021-12-31","value":-23.62,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":7.21,"profit":true}] |
Income Taxes | 137.60M | (51.30M) | 604.70M | 734.60M | 148.20M | [{"date":"2019-12-31","value":18.73,"profit":true},{"date":"2020-12-31","value":-6.98,"profit":false},{"date":"2021-12-31","value":82.32,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":20.17,"profit":true}] |
Income After Taxes | 16.80M | (669.90M) | (1.27B) | 2.08B | 54.70M | [{"date":"2019-12-31","value":0.81,"profit":true},{"date":"2020-12-31","value":-32.23,"profit":false},{"date":"2021-12-31","value":-61.06,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.63,"profit":true}] |
Income From Continuous Operations | 16.80M | (669.90M) | (1.27B) | 2.08B | 1.83B | [{"date":"2019-12-31","value":0.81,"profit":true},{"date":"2020-12-31","value":-32.23,"profit":false},{"date":"2021-12-31","value":-61.06,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.11,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 16.80M | (669.90M) | (1.27B) | 2.08B | 54.70M | [{"date":"2019-12-31","value":0.81,"profit":true},{"date":"2020-12-31","value":-32.23,"profit":false},{"date":"2021-12-31","value":-61.06,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.63,"profit":true}] |
EPS (Diluted) | 4.42 | 4.40 | 3.69 | 3.35 | 2.93 | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":99.55,"profit":true},{"date":"2021-12-31","value":83.48,"profit":true},{"date":"2022-12-31","value":75.79,"profit":true},{"date":"2023-12-31","value":66.29,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
VTRS | |
---|---|
Cash Ratio | 0.27 |
Current Ratio | 1.51 |
Quick Ratio | 0.96 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
VTRS | |
---|---|
ROA (LTM) | 2.48% |
ROE (LTM) | -4.34% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
VTRS | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.56 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.44 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
VTRS | |
---|---|
Trailing PE | NM |
Forward PE | 4.56 |
P/S (TTM) | 0.99 |
P/B | 0.76 |
Price/FCF | 20 |
EV/R | 1.92 |
EV/Ebitda | 12.00 |
PEG | 0.08 |
Viatris Inc (VTRS) share price today is $12.445
Yes, Indians can buy shares of Viatris Inc (VTRS) on Vested. To buy Viatris Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VTRS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Viatris Inc (VTRS) via the Vested app. You can start investing in Viatris Inc (VTRS) with a minimum investment of $1.
You can invest in shares of Viatris Inc (VTRS) via Vested in three simple steps:
The 52-week high price of Viatris Inc (VTRS) is $13.55. The 52-week low price of Viatris Inc (VTRS) is $9.74.
The price-to-earnings (P/E) ratio of Viatris Inc (VTRS) is
The price-to-book (P/B) ratio of Viatris Inc (VTRS) is 0.76
The dividend yield of Viatris Inc (VTRS) is 3.83%
The market capitalization of Viatris Inc (VTRS) is $14.94B
The stock symbol (or ticker) of Viatris Inc is VTRS